CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 120 filers reported holding CUREVAC N V in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,428,112 | +9.3% | 209,094 | +66.8% | 0.00% | +100.0% |
| Q2 2023 | $1,306,116 | +22.8% | 125,347 | -17.9% | 0.00% | 0.0% |
| Q1 2023 | $1,063,594 | +335.5% | 152,596 | +276.8% | 0.00% | – |
| Q4 2022 | $244,215 | -64.3% | 40,500 | +16.0% | 0.00% | -100.0% |
| Q1 2022 | $684,000 | -42.9% | 34,900 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,197,000 | -37.2% | 34,900 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $1,906,000 | -40.7% | 34,900 | -0.6% | 0.00% | -50.0% |
| Q1 2021 | $3,213,000 | +36.0% | 35,125 | +20.6% | 0.00% | +33.3% |
| Q4 2020 | $2,362,000 | – | 29,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |